Why Elan Is Inviting Royalty Pharma Bid

June 17 (Bloomberg) -- Elan Corp. is seeking a buyer and will invite Royalty Pharma, whose $6.7 billion bid it rejected, to participate, suggesting the two companies may end a standoff that has lasted almost four months. Jonathan Ferro reports on Bloomberg Television's "Countdown." (Source: Bloomberg)

Pimco's Balls Says U.S. Rate Risk 'Attractive' Vs. World
08:46 - Andrew Balls, chief investment officer of global fixed income at Pimco, discusses the Federal Reserve's ability to begin normalizing interest rates while the rest of the world remains near the zero-bound environment. He speaks on "Bloomberg Surveillance." (Source: Bloomberg)
  • Iron Ore Seen at Risk of 2017 Price Slump to $50s
  • Seven Arrested in Connection With London Terror Attack
  • Full Show: Bloomberg Daybreak: Americas (03/22)